42_Watch Out. Europe Is Gaining Ground Over The U.S. In Cannabis Medicine

Michael Sassano, CEO of Somai Pharmaceuticals, a European pharmaceutical, and biotech company centered on manufacturing in Lisbon, Portugal says the data is clear. The US may have more research funds, but they are stymied by the lack of legalization and Europe is about to take the lead on testing and clinical trials.

Michael is one of the most respected executives in the pharmaceutical cannabis space today. And he is celebrated in mainstream business and biopharma media as an international authority on developing large-scale cannabis infrastructures throughout the world and the most advanced pharmaceutical cannabinoid products.

He is also widely respected for successfully predicting long term cannabis market trends and movements, which he generously shares in many forums.

https://www.somaipharma.eu/
https://www.linkedin.com/in/michaelsassano3/

The Mary Jane Society is produced and hosted by Pam Chmiel, a journalist, freelance writer, and marketing and PR specialist in the cannabis industry. Get in touch to discuss your business strategy or explore working together at pam@TheMaryJaneSociety.com.

LinkedIn   Twitter   Instagram

Please like the show to help us reach more listeners🙏🏻